Journal of Clinical Immunology

, Volume 25, Issue 2, pp 162–173 | Cite as

Akhil Kakroo

  • Wen-I Lee
  • Ming-Ling Kuo
  • Jing-Long Huang
  • Syh-Jae Lin
  • Cheng-Jang Wu


Recent advances in immunologic techniques have lead to increased recognition of primary immunodeficiencies. A review of patients with suspected immunodeficiencies in a Taiwan tertiary hospital from January 1985 to October 2004 and molecular/genetic analyses done on some patients were investigated. Of the 403 patients selected based on the International Classification of Disease, Ninth Revision, 37 patients with PID (8 females and 29 males) were identified: 17 (46%) with antibody production deficiencies, nine (24%) with defective phagocyte function, four (11%) with combined B and T cell immunodeficiencies, seven (19%) with T cell deficiencies, but none with primary complement deficiencies. Those with secondary immunodeficiencies were excluded from the study. Recurrent sinopulmonary infections (62%) were the most common clinical manifestation, followed by sepsis (57%), severe skin infection (40%), splenomagaly/hepatomegaly (27%), central nervous system dysfunction (22%), chronic diarrhea (22%), and failure to thrive (19%). Seven (19%) patients died, five of infections, one of disseminated intravascular coagulopathy and one of hepatocellular carcinoma. Six novel mutations were found from 11 agreed patients. This is the first report on primary immunodeficiencies in Taiwan covering a 20-year period.

Primary immunodeficiency agammaglobulinemia recurrent sinopulmonary infections unrelated umbilical cord stem cell transplantation Taiwan 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Stiehm ER, Ochs HD, Winkelstein JA: Immunologic disorders: General considerations. In Immunodeficiency Disorders in Infants & Children, ER Stiehm, HD Ochs, JA Winkelstein (eds). Philadelphia, WB Saunders, 2004, pp 289–355Google Scholar
  2. 2.
    Bruton OC: Agammaglobulinemia. Pediatrics 9:772–728, 1952Google Scholar
  3. 3.
    Smith CIE, Ochs HD, Puck JM: Genetically determined immunodeficiency diseases: A perspective. In Primary immunodeficiency diseases, HD Ochs, CIE Smith, JM Puck (eds). New York, Oxford, 1999, pp 3–11Google Scholar
  4. 4.
    Stiem ER, Chin TW, Hass A, Peerless AG: Infectious complications of primary immunodeficiencies. Clin Immunol Immunopathol 40:69–89, 1986Google Scholar
  5. 5.
    Webster ABD: Infection in primary immunodeficiency syndrome. Curr Opin Infect Dis 7:444–449, 1994Google Scholar
  6. 6.
    WHO scientific group: Primary immunodeficiency disease. J Clin Exp Immunol supp 1:1–28, 1997Google Scholar
  7. 7.
    Lin TY, Chiang BL: Specific immune response in adult medical personnel immunized with acellular pertusis vaccine with special emphasis on T helper cell response. Vaccine 15:1917–1921, 1997Google Scholar
  8. 8.
    Godoy-Ramirez K, Franck K, Gaines H: A novel method for the simulataneous assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell level by multi-parameter flow cytometry. J Immunol Methods 239:35–44, 2000Google Scholar
  9. 9.
    Lin SJ, Cheng PL, Huang YJ, Kou ML: Evaluation of cytotoxic function and apoptosis in interleukin (IL)-12/IL-15-treated umbilical cord or adult peripheral blood natural killer cell by a propidium-iodide based flow cytometry. Pediatr Allergy Immunol 15:79–85, 2004Google Scholar
  10. 10.
    Futatani T, Miyawaki T, Tsukada S, Hashimoto S, Kunikata T, Arai S, Kurimoto M, Niida Y, Matsuoka H, Sakiyama Y, Iwata T, Tsuchiya S, Tatsuzawa O, Yoshizaki K, Kishimoto T: Deficient expression of Bruton’s tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 91:595–602, 1998Google Scholar
  11. 11.
    Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, Ochs HD: Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 92:2421–2434, 1998Google Scholar
  12. 12.
    Puck JM, Pepper AE, Henthorn PS, Candotti F, Isakov J, Whitwam T, Conley ME, Fischer RE, Rosenblatt HM, Small TN, Buckley RH: Mutations analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood 89:1968–1977, 1997Google Scholar
  13. 13.
    Zhu Q, Watanabe C, Liu T, Hollenbaugh D, Blaese RM, Kanner SB, Aruffo A, Ochs HD: Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP mutations, protein expression, and phenotype. Blood 90:2680–2689, 1997Google Scholar
  14. 14.
    Lee WI, Zhu Q, Gambineri E, Jin Y, Welcher A, Ochs HD: Inducible CO-Stimulator molecule (ICOS), a candidate gene for defective isotype switching, is normal in patients with Hyper IgM syndrome of unknown molecular diagnosis. J Allergy Clin Immunol 112:958–964, 2003Google Scholar
  15. 15.
    Driscoll DA, Salvin J, Sellinger B, Budarf ML, McDonald-McGinn DM, Zackai EH, Emanuel BS: Prevalence of 22q11 microdelletions in DiGeorge and velocardiofacial syndromes: Implications for genetic counseling and prenatal diagnosis. J Med Genet 30:813–817, 1993Google Scholar
  16. 16.
    David D, Bani L, Moreau JL, Demaison C, Sun K, Salvucci O, Nakarai T, de Montalembert M, Chouaib S, Joussemet M, Ritz J, Theze J: Further analysis of IL-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets. Blood 91:165–172, 1998Google Scholar
  17. 17.
    Freyer DR, Gowans LK, Warzynski M, Lee WI: Flow cytometeric diagnosis of X-linked hyper-IgM syndrome: Application of an accurate and convenient procedure. J Pediatr Hematol Oncol 6:262–370, 2004Google Scholar
  18. 18.
    Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD: Mutation analysis in a large cohort patients with hyper IgM syndrome. Blood 105:1881–1890, 2005Google Scholar
  19. 19.
    Monis-Teisserenc HT, Gadola SD, Cella M: Association of a syndrome rembling Wegener’s granulomatosis with low surface expression of HLA-class-I molecules. Lancet 354:1598–1603, 1999CrossRefPubMedGoogle Scholar
  20. 20.
    Report on Registeration of Births and Deaths, 2004. Registry of Births and Deaths, National Registeration Department, TaiwanGoogle Scholar
  21. 21.
    DiGerge AM: Discussion on a new concept of the cellular basis of immunology. J Pediatr 67:907, 1965Google Scholar
  22. 22.
    Conley ME, Beckwith JB, Mancer JFK, Tenckhoff L: The spectum of the DiGerge syndrome. J Pediatr 94:883–890, 1979Google Scholar
  23. 23.
    Lim DL, Thong BY, Ho SY, Shek LP, Lou J, Leong KP, Chng HH, Lee BW: Primary immunodeficiency diseases in Singapore-the last 11 years. Singapore Med J 44:579–586, 2003Google Scholar
  24. 24.
    Fasth A: Primary immunodeficiency disorders in Sweden: Cases among children. 1974–1979. J Clin Immunol 2:86–92, 1982Google Scholar
  25. 25.
    Hayakawa H, Iwata T, Yata J, Kobayashi N: Primary immunodeficiency syndrome in Japan. Overview of a nationwide survey on primary immunodeficiency syndrome. J Clin Immunol 1:31–39, 1981Google Scholar
  26. 26.
    Luzi G, Businco L, Aiuti F: Primary immunodeficiency syndromes in Italy: A report of the national register in children and adults. J Clin Immunol 3:316–320, 1983Google Scholar
  27. 27.
    Ryser O, Morell A, Hitzig WH: Primary immunodeficiencies in Switzerland: First report of the national registry in adults and children. J Clin Immunol 8:479–485, 1988Google Scholar
  28. 28.
    Gooi HC: Primary immunodeficiency register, United Kingdom: Update 1992. Immunodeficiency 4:191–192, 1993Google Scholar
  29. 29.
    Affentranger P, Morell A, Spath P, Seger R: Registry of primary immunodeficiencies in Switzerland. Immunodeficiency 4:193–195, 1993Google Scholar
  30. 30.
    Grumach AS, Duarte AJ, Bellinati-Pires R, Pastorino AC, Jacob CM, Diogo CL, Condino-Neto A, Kirschfink M, Carneiro-Sampaio MM: Brazilian report on primary immunodeficiencies in children: 166 Cases studied over a follow-up time of 15 years. J Clin Immunol 17:340–345, 1997Google Scholar
  31. 31.
    Matamoros FN, Mila LJ, Espanol BT, Raga BS, Fontan CG: Primary immunodeficiency syndrome in Spain: First report of the National Registry in children and adults. J Clin Immunol 17:333–339, 1997Google Scholar
  32. 32.
    Zelazko M, Carneiro-Sampaio M, Cornejo de Luigi M, Garcia de Olarte D, Porras Madrigal O, Berron Perez R, Cabello A, Rostan MV, Sorensen RU: Primary immunodeficiency diseases in Latin America: First report from eight countries participating in the LAGID. Latin American Group for Primary Immunodeficiency Diseases. J Clin Immunol 18:161–166, 1998Google Scholar
  33. 33.
    Elder ME: T-cell immunodeficiencies. Pediatr Clin North Am 47:1253–1274, 2000Google Scholar
  34. 34.
    Primary immunodeficiency disease-report of an IUIS scientific committee. Clin Exp Immunol 118 (Suppl 1):1–28, 1999Google Scholar
  35. 35.
    Chapel HM, Webster ADB: Assessment of the immune system. In Primary Immunodeficiency Diseases, HD Ochs, CIE Smith, JM Puck (eds). New York, Oxford, 1999, pp 419–431Google Scholar
  36. 36.
    Quartier P, Debre M, De Blic J, de Sauverzac R, Sayegh N, Jabado N, Haddad E, Blanche S, Casanova JL, Smith CI, Le Deist F, de Saint Basile G, Fischer A: Early and prolonged intravenous immunoglobulin replacement therapy in childhood aggammaglobulinemia: A retrospetic survey of 31 patients. J Pediatr 134:589–596, 1999Google Scholar
  37. 37.
    Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, Myers LA, Ward FE: Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 340:508–516, 1999Google Scholar
  38. 38.
    Knutsen AP, Wall DA: Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: Two-year experience. J Clin Immunol 20:466–476, 2000Google Scholar
  39. 39.
    Ozsahin H, Le Deist F, Benkerrou M, Cavazzana-Calvo M, Gomez L, Griscelli C, Blanche S, Fischer A: Bone marrow transplantation in 26 patients with Wiskott–Aldrich syndrome from a single center. J Pediatr 129:238–244, 1996Google Scholar
  40. 40.
    Thrasher A, Goldblatt D: Hematopoietic-cell transplantation for chronic granulomatous disease. N Engl J Med 345:377–378, 2001Google Scholar
  41. 41.
    Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis-Girod S, Fischer A, Davies EG, Kuis W, Leiva L, Cavazzana-Calvo M: Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346:1185–1193, 2002Google Scholar
  42. 42.
    Fischer A, Hacein-Bey S, Cavazzana-Calvo M: Gene therapy of severe combined immunodeficiencies. Nat Rev Immunol 2:615–621, 2002Google Scholar
  43. 43.
    Cunningham-Rundles C, Sidi P, Estrella L, Doucette J: Identifying undiagnosed primary immunodeficiency diseases in minority subjects by using computer sorting of diagnosis codes. J Allergy Clin Immunol 113:747–755, 2004Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Wen-I Lee
    • 1
    • 2
    • 4
  • Ming-Ling Kuo
    • 3
    • 4
  • Jing-Long Huang
    • 2
  • Syh-Jae Lin
    • 2
  • Cheng-Jang Wu
    • 2
  1. 1.Graduate Institute of Clinical Medical SciencesChang Gung University, Chang Gung Children’s HospitalTaiwan
  2. 2.Department of Pediatric Allergy, Immunology and RheumatologyChang Gung University, Chang Gung Children’s HospitalTaiwan
  3. 3.Department of Microbiology and ImmunologyGraduate Institute of Basic Medical Sciences, Chang Gung University, Chang Gung Children’s HospitalTaiwan
  4. 4.Department of Pediatric Allergy, Immunology, and RheumatologyChang Gung University and Chang Gung Children’s HospitalKwei-ShanTaiwan

Personalised recommendations